1. Azacitidine-related risk of differentiation syndrome

   News item 29 April 2023 Pages: 1 - 1

2. Diclofenac suppository may cause acute necrotising encephalopathy of childhood

   News item 29 April 2023 Pages: 2 - 2

3. Low-dose quetiapine as sleep aid may cause serious AEs

   News item 29 April 2023 Pages: 3 - 3

4. Measures to reduce risk of miltefosine-related eye disorders

   News item 29 April 2023 Pages: 4 - 4

5. Subcutaneous atrophy at triamcinolone injection site

   News item 29 April 2023 Pages: 5 - 5

6. AEs common and preventable in aged-care residents

   Clinical study 29 April 2023 Pages: 6 - 6

7. Antibacterial exposure in-utero or in infancy increases risk of autism and ADHD

   Clinical study 29 April 2023 Pages: 7 - 7

8. Frequency of drug-induced anaphylaxis and fatal anaphylaxis in Japan

   Clinical study 29 April 2023 Pages: 8 - 8

9. Impact of Janusmed Risk Profile on AEs in older patients receiving polypharmacy

   Clinical study 29 April 2023 Pages: 9 - 9

10. Longer interval between last ICI dose and first TKI dose reduces risk of SAEs

    Clinical study 29 April 2023 Pages: 10 - 10

11. Voriconazole, risk of periostitis

    Clinical study 29 April 2023 Pages: 11 - 11

12. Other adverse reaction research

    News item 29 April 2023 Pages: 12 - 12

13. Aceclofenac

    Case report 29 April 2023 Pages: 13 - 13

14. Acetazolamide/antihypertensives/potassium-sparing-diuretics

    Case report 29 April 2023 Pages: 14 - 14

15. Aciclovir/dexamethasone

    Case report 29 April 2023 Pages: 15 - 15

16. Aciclovir/immune globulin/methylprednisolone sodium succinate

    Case report 29 April 2023 Pages: 16 - 16

17. Ad26.cov2-s

    Case report 29 April 2023 Pages: 17 - 17

18. Adalimumab

    Case report 29 April 2023 Pages: 18 - 18

19. Adenosine

    Case report 29 April 2023 Pages: 19 - 19

20. Afatinib

    Case report 29 April 2023 Pages: 20 - 20

21. Albendazole

    Case report 29 April 2023 Pages: 21 - 21

22. Aldesleukin/cyclophosphamide

    Case report 29 April 2023 Pages: 22 - 22

23. Alectinib

    Case report 29 April 2023 Pages: 23 - 23

24. Alteplase

    Case report 29 April 2023 Pages: 24 - 24

25. Alteplase/aspirin/enoxaparin-sodium

    Case report 29 April 2023 Pages: 25 - 25

26. Amifampridine/levofloxacin

    Case report 29 April 2023 Pages: 26 - 26

27. Amiodarone

    Case report 29 April 2023 Pages: 27 - 27

28. Amiodarone

    Case report 29 April 2023 Pages: 28 - 28

29. Amiodarone/metoprolol/tagraxofusp

    Case report 29 April 2023 Pages: 29 - 29

30. Amlodipine/indapamide/perindopril

    Case report 29 April 2023 Pages: 30 - 30

31. Amphotericin B liposomal/isavuconazole/micafungin

    Case report 29 April 2023 Pages: 31 - 31

32. Amphotericin-b-liposomal/itraconazole/miltefosine

    Case report 29 April 2023 Pages: 32 - 32

33. Anti-infectives/antineoplastics

    Case report 29 April 2023 Pages: 33 - 33

34. Antiallergics/montelukast

    Case report 29 April 2023 Pages: 34 - 34

35. Antibacterials

    Case report 29 April 2023 Pages: 35 - 35

36. Antibacterials

    Case report 29 April 2023 Pages: 36 - 36

37. Antibacterials/antiepileptic-drugs

    Case report 29 April 2023 Pages: 37 - 37

38. Antibacterials/atezolizumab/bevacizumab

    Case report 29 April 2023 Pages: 38 - 38

39. Antibacterials/immune-globulin/tozinameran

    Case report 29 April 2023 Pages: 39 - 39

40. Antidepressants

    Case report 29 April 2023 Pages: 40 - 40

41. Antidepressants

    Case report 29 April 2023 Pages: 41 - 41

42. Antiepileptics

    Case report 29 April 2023 Pages: 42 - 42

43. Antifungals/antineoplastics

    Case report 29 April 2023 Pages: 43 - 43

44. Antifungals/cotrimoxazole/dexamethasone

    Case report 29 April 2023 Pages: 44 - 44

45. Antihyperglycemics

    Case report 29 April 2023 Pages: 45 - 45

46. Antineoplastics

    Case report 29 April 2023 Pages: 46 - 46

47. Antineoplastics

    Case report 29 April 2023 Pages: 47 - 47

48. Antineoplastics

    Case report 29 April 2023 Pages: 48 - 48

49. Antineoplastics

    Case report 29 April 2023 Pages: 49 - 49

50. Antineoplastics

    Case report 29 April 2023 Pages: 50 - 50